Table 1.
Correlation between serum vaspin levels and age, glycemia, body fat distribution, indices for insulin secretion and insulin resistance (HOMA-β, HOMA-IR) and hsCRP in the groups according to glucose tolerance [normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and newly-diagnosed type 2 diabetes (NDT2D)] and the presence of Metabolic syndrome (MetS)
| Vaspin | Vaspin | ||||
|---|---|---|---|---|---|
| Corr coeff (r) | P | Corr coeff (r) | P | ||
| NGT | IFG | ||||
| Age | 0.35 | 0.003 | Age | 0.16 | 0.373 |
| Fasting plasma glucose | 0.1 | 0.394 | Fasting plasma gucose | 0.01 | 0.992 |
| HbA1c | 0.17 | 0.157 | HbA1c | −0.17 | 0.325 |
| AGEs | 0.18 | 0.144 | AGEs | −0.12 | 0.486 |
| BMI | −0.01 | 0.987 | BMI | 0.14 | 0.431 |
| Total body fat | 0.23 | 0.055 | Total body fat | −0.05 | 0.762 |
| Visceral fat area | 0.12 | 0.318 | Visceral fat area | 0.22 | 0.212 |
| Fasting serum insulin | −0.16 | 0.178 | Fasting serum insulin | 0.15 | 0.407 |
| HOMA-β | −0.18 | 0.143 | HOMA-β | 0.12 | 0.483 |
| HOMA-IR | −0.14 | 0.237 | HOMA-IR | 0.16 | 0.371 |
| hsCRP | 0.08 | 0.518 | hsCRP | −0.23 | 0.188 |
| NGT + MetS | IGT | ||||
| Age | 0.31 | 0.042 | Age | 0.23 | 0.201 |
| Fasting plasma glucose | 0.05 | 0.768 | Fasting plasma glucose | 0.13 | 0.451 |
| HbA1c | 0.25 | 0.140 | HbA1c | 0.18 | 0.313 |
| AGEs | 0.45 | 0.006 | AGEs | 0.07 | 0.710 |
| BMI | 0.11 | 0.533 | BMI | −0.28 | 0.107 |
| Total body fat | 0.28 | 0.110 | Total body fat | −0.3 | 0.088 |
| Visceral fat area | 0.1 | 0.560 | Visceral fat area | −0.25 | 0.156 |
| Fasting serum insulin | −0.25 | 0.148 | Fasting serum insulin | −0.1 | 0.451 |
| HOMA-β | −0.25 | 0.148 | HOMA-β | −0.19 | 0.286 |
| HOMA-IR | −0.24 | 0.165 | HOMA-IR | −0.05 | 0.779 |
| hsCRP | 0.14 | 0.438 | hsCRP | −0.17 | 0.325 |
| NGT – MetS | NDT2D | ||||
| Age | 0.41 | 0.015 | Age | 0.05 | 0.791 |
| Fasting plasma glucose | 0.24 | 0.168 | Fasting plasma glucose | −0.4 | 0.023 |
| HbA1c | 0.11 | 0.529 | HbA1c | −0.37 | 0.036 |
| AGEs | −0.05 | 0.799 | AGEs | −0.11 | 0.539 |
| BMI | −0.05 | 0.771 | BMI | 0.26 | 0.138 |
| Total body fat | 0.21 | 0.222 | Total body fat | 0.43 | 0.013 |
| Visceral fat area | 0.28 | 0.102 | Visceral body fat | 0.06 | 0.740 |
| Fasting serum insulin | −0.01 | 0.939 | Fasting serum insulin | 0.12 | 0.504 |
| HOMA-β | −0.09 | 0.618 | HOMA-β | 0.29 | 0.101 |
| HOMA-IR | 0.02 | 0.918 | HOMA-IR | −0.06 | 0.736 |
| hsCRP | 0.11 | 0.543 | hsCRP | −0.04 | 0.835 |
| MetS+ | MetS− | ||||
| Age | 0.22 | 0.019 | Age | 0.36 | 0.006 |
| Fasting plasma glucose | 0.16 | 0.079 | Fasting plasma glucose | 0.18 | 0.185 |
| HbA1c | 0.15 | 0.110 | HbA1c | 0.09 | 0.531 |
| AGEs | 0.2 | 0.036 | AGEs | −0.16 | 0.242 |
| BMI | 0.17 | 0.074 | BMI | −0.13 | 0.348 |
| Total body fat | 0.2 | 0.032 | Total body fat | 0.04 | 0.797 |
| Visceral fat area | 0.16 | 0.094 | Visceral fat area | 0.01 | 0.958 |
| Fasting serum insulin | 0.06 | 0.525 | Fasting serum insulin | −0.14 | 0.325 |
| HOMA-β | −0.01 | 0.886 | HOMA-β | −0.21 | 0.130 |
| HOMA-IR | 0.09 | 0.347 | HOMA-IR | −0.08 | 0.553 |
| hsCRP | 0.01 | 0.916 | hsCRP | −0.07 | 0.625 |
Statistical significant values are presented in italics